Login / Signup

Use of Mitomycin-C in Laryngotracheal Stenosis: A Focused Clinical Review.

Christopher Di FeliceMichael S MachuzakRay W Shepherd
Published in: Journal of bronchology & interventional pulmonology (2023)
The role for MMC as an adjunct therapy in LTS is uncertain. While safe in its application, the efficacy of MMC in reducing stenosis recurrence remains a matter of debate. Large, prospective studies are needed to inform future recommendations.
Keyphrases
  • current status
  • clinical practice
  • case control
  • free survival
  • bone marrow
  • cell therapy